Characteristics

Case (n = 17)

Control (n = 66)

Odds ratio

95% CI

p

Male gender

13 (77)

46 (70)

1.41

0.36 - 5.90

0.766

Age in months (median, IQR)

7.0 (2.5, 13.5)

12.0 (4.9, 27.0)

-

-

0.098

High fever (axillary temperature ≥ 39˚)

8 (47)

28 (42)

1.21

0.36 - 3.98

0.944

Seizure

13 (87)

52 (84)

1.25

0.21 - 9.41

1.000

Altered mental status/unconsciousness

12 (71)

28 (42)

3.26

0.92 - 12.13

0.071

Preceding respiratory symptoms (cough, difficult breathing)

11 (69)

21 (33)

4.50

1.23 - 17.37

0.019

Preceding GI symptoms (diarrhea, vomiting)

11 (65)

58 (88)

0.30

0.07 - 1.32

0.118

H/O Febrile convulsion

1 (14)

3 (11)

1.39

0.0 - 21.16

1.000

H/O taking antibiotics during this illness

11 (79)

20 (53)

3.30

0.68 - 17.87

0.169

Severe wasting

3(30)

9(23)

1.43

0.23 - 8.26

0.689

Respiratory rate (mean ± SD), MD*

50.1 ± 13.1

45.9 ± 13.2

4.14*

−3.22 - 11.50

0.266

Dehydration (some/severe)

9 (53)

29 (44)

1.20

0.36 - 40.03

0.952

Hypoglycemia at presentation (<3 mmol/l)

1 (8)

5 (9)

0.83

-

1.000

Neck rigidity

4 (40)

6 (23)

2.22

0.36 - 13.89

0.912

Kernig sign

1 (13)

5 (21)

0.54

0.02 - 6.72

1.000

Brudzinski sign

1(20)

1 (13)

1.75

0.0 - 92.99

1.000

Abnormal DTR

10 (59)

19 (29)

3.16

0.29 - 79.69

0.399

Abnormal planter response

11 (65)

40 (60)

0.82

0.19 - 3.76)

0.792

Severe sepsis

10 (59)

11 (17)

7.14

1.95 - 27.13

0.0009

Associated anemia

9 (53)

30 (45)

1.31

0.40 - 4.35

0.821

Hypernatremia at admission (s. sodium >150 mmol/l)

3 (18)

9 (14)

1.33

0.25 - 6.50

0.706

Hyponatremia at admission (s. sodium <135 mmol/l)

9 (53)

26 (40)

1.69

0.51 - 5.62

0.492

Leucocytosis at admission

10 (59)

17 (26)

4.03

1.17 - 14.25

0.024

Neutrophillia at admission

7 (41)

9 (14)

4.36

1.13 - 17.00

0.018

AWD

6 (35)

24 (36)

1.08

0.30 - 3.90

0.874

Pneumonia

7 (41)

10 (15)

4.64

1.17 - 18.70

0.016

Hypoxaemia (SpO2 < 90%)

10 (63)

14 (23)

5.71

1.55 - 21.93

0.004

Anti seizure agent given

16 (94)

50 (76)

5.12

0.62 - 111.48

0.174

Blood transfusion given

5 (29)

5 (8)

5.00

1.04 - 24.59

0.028

Use of inotropes

5 (29)

4 (6)

6.46

1.25 - 34.85

0.015

ET intubation & MV required

3 (18)

1 (2)

13.29

1.09 - 359.20

0.028

Growth in blood culture

4 (29)

9 (14)

2.44

0.51 - 11.30

0.234

Growth in urine culture

4 (29)

14 (22)

1.37

0.25 - 7.38

0.715

Growth in stool culture

0

10 (15)

0

0 - 1.95

0.114

Outcome (death)

5 (29)

2 (3)

13.33

1.93 - 114.53

0.003